Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors

NCT03644056 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Metastasis
Locally Advanced

Interventions

DRUG: IMC-001

Sponsor

ImmuneOncia Therapeutics Inc.